Sangjin Kim

13PUBLICATIONS
35CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCounselling, wellbeing and community services
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 20, 2026
Outcomes of Highly Urgent ABO-Incompatible Living Donor Liver Transplantation in National Databases.

Jongman Kim, Sang Jin Kim, Boram Park

|May 12, 2025
Comparison of initial treatments for resectable hepatocellular carcinoma within Milan criteria: an observational study based on a nationwide survey.

Sang Jin Kim, Woo Kyoung Jeong, Hyung-Joon Han

|Aug 29, 2024
Impact of Baseline Anti-ABO Antibody Titer on Biliary Complications in ABO-Incompatible Living-Donor Liver Transplantation.

Se-Hyeon Yu, Hye-Sung Jo, Young-Dong Yu

|Jun 29, 2023
Liver transplantation for hepatocellular carcinoma with portal vein tumor thrombosis.

Sang Jin Kim, Jong Man Kim

|Jun 30, 2022
Early reoperation after adult living-donor liver transplantation is associated with poor survival.

Manuel Lim, Jinsoo Rhu, Sangjin Kim

Pageof 3